For colon cancer treatment they are harvested or isolated from the patient’s own blood. Next, they are expanded or multiplied in the lab. A biopsy of the patients own colon cancer is also needed for this treatment. A fresh or frozen biopsy of the patient’s own colon cancer will be used to “educated” or prime the expanded cells to recognize the patient’s own colon cancer as an invader. These cells will be returned back to the patient, usually one week later, through an intravenous drip or IV. The “educated” dendritic cells then go educate white blood cells and they attack the colon cancer in the patient. This IV is done on a monthly basis, depending on the patient’s colon cancer and the doctor’s treatment protocol.
The future of dendritic cell therapy, predicted 5 years ago by Stanford Medical Researcher. This presentation is from 2007. This type of colon cancer treatment is available today for patients with early stage colon cancer who prefer to opt for immunotherapy as a first course of action.
|The following poster board discusses 39 colon cancer patients with hematogenous spread of their disease and after failure of primary standard therapy and dendritic cell therapy.|
Trio get Nobel for Medicine
Three scientists who unlocked the secrets of the body’s immune system have won the 2011 Nobel prize for medicine.
< See news >